abstract |
The present invention relates to the field of cancer and inflammatory diseases. Specifically, the purpose of said invention is to provide novel conjugated forms of active principles belonging to the family of dolastatins and of formula (I). In addition, said invention is aimed at prodrug forms of said conjugates. |